Form 8-K - Current report:
SEC Accession No. 0000950170-25-067511
Filing Date
2025-05-09
Accepted
2025-05-09 08:00:08
Documents
12
Period of Report
2025-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmvp-20250509.htm   iXBRL 8-K 54109
2 EX-99.1 pmvp-ex99_1.htm EX-99.1 143782
  Complete submission text file 0000950170-25-067511.txt   329147

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pmvp-20250509.xsd EX-101.SCH 30682
14 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20250509_htm.xml XML 4720
Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 25928430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)